comparemela.com

Page 3 - Wayne Batchelor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

Operators have a choice of two devices, Neal Kleiman says. “I’m glad to see we’ve got a field that’s evolving and competitive.”

United statesYousif ahmadRobertl smithNeal kleimanWayne batchelorMitraclip abbottPascal edwards lifesciencesBaylor scott whiteFiras zahrAmerican college of cardiologyMd oregon health science universityMd houston methodist debakey heart vascular centerMd inova health systemPhd yale school of medicineEdwards lifesciencesBaylor scott

Big Step Forward for Transcatheter Tricuspid Valve Replacement: TRISCEND II

TR was eliminated, safety looked good, and symptoms improved all good news for hard-to-treat patients, say experts.

New yorkUnited statesTown hallSuzanne arnoldRoxana mehranEvoque edwards lifesciencesSusheel kodaliTriclip abbottSam dawkinsNir urielWayne batchelorNeil famDrug administrationMd saint luke mid america heart instituteMd university of toronto stVascular institute

Tricuspid Valve Replacement Safe, Effective in Pivotal Trial

Outcome data still awaited after positive interim results

United statesNew havenNew yorkYousif ahmadWayne batchelorSusheel kodaliCardiovascular research foundationVascular institute in falls churchSociety of thoracic surgeonsYork heart associationYale school of medicineColumbia university irving medical centerNew york cityTranscatheter cardiovascular therapeuticsCardiovascular researchYale school

Mitral Valve TEER Device Horse Race Draws Even Closer

Additional patients in pivotal trial add to strength of the findings

Falls churchUnited statesNew yorkNew havenFiras zahrRoxana mehranYousif ahmadWayne batchelorBaylor scottRobert smithJason rogersVascular in falls churchIcahn school of medicine at mount sinaiOregon health science university in portlandCardiovascular research foundationUniversity of california davis

Small Aortic Annuli Not Inherently More Amenable to TAVR

TAVR, SAVR result in similar outcomes in female-dominated VIVA randomized trial

New havenUnited statesNew yorkWayne batchelorNicole louYousif ahmadRoxana mehranMount sinai health systemCardiovascular research foundationLaval universityYale school of medicineVascular institute in falls churchSociety of thoracic surgeonsQuebec heart lung instituteQuebec heartLung institute

vimarsana © 2020. All Rights Reserved.